JP2023544300A5 - - Google Patents

Info

Publication number
JP2023544300A5
JP2023544300A5 JP2023519355A JP2023519355A JP2023544300A5 JP 2023544300 A5 JP2023544300 A5 JP 2023544300A5 JP 2023519355 A JP2023519355 A JP 2023519355A JP 2023519355 A JP2023519355 A JP 2023519355A JP 2023544300 A5 JP2023544300 A5 JP 2023544300A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
variant
substitution
lukb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023519355A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544300A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/052418 external-priority patent/WO2022067255A2/en
Publication of JP2023544300A publication Critical patent/JP2023544300A/ja
Publication of JP2023544300A5 publication Critical patent/JP2023544300A5/ja
Pending legal-status Critical Current

Links

JP2023519355A 2020-09-28 2021-09-28 バリアントstaphylococcus aureus luka及びlukbポリペプチド並びにワクチン組成物 Pending JP2023544300A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063084273P 2020-09-28 2020-09-28
US63/084,273 2020-09-28
PCT/US2021/052418 WO2022067255A2 (en) 2020-09-28 2021-09-28 Variant staphylococcus aureus luka and lukb polypeptides and vaccine compositions

Publications (2)

Publication Number Publication Date
JP2023544300A JP2023544300A (ja) 2023-10-23
JP2023544300A5 true JP2023544300A5 (https=) 2024-10-07

Family

ID=80846955

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023519355A Pending JP2023544300A (ja) 2020-09-28 2021-09-28 バリアントstaphylococcus aureus luka及びlukbポリペプチド並びにワクチン組成物

Country Status (15)

Country Link
US (1) US20240050546A1 (https=)
EP (1) EP4216982A4 (https=)
JP (1) JP2023544300A (https=)
KR (1) KR20230091911A (https=)
CN (1) CN116670158A (https=)
AR (1) AR123635A1 (https=)
AU (1) AU2021350860A1 (https=)
CA (1) CA3195895A1 (https=)
CL (1) CL2023000884A1 (https=)
CO (1) CO2023004198A2 (https=)
IL (1) IL301406A (https=)
JO (1) JOP20230065A1 (https=)
MX (1) MX2023003581A (https=)
NZ (1) NZ798451A (https=)
WO (1) WO2022067255A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3215751A1 (en) * 2021-04-02 2022-10-06 Janssen Pharmaceuticals, Inc. Staphylococcus aureus vaccine compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340522C (en) * 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
SE0102327D0 (sv) * 2001-06-28 2001-06-28 Active Biotech Ab A novel engineered superantigen for human therapy
EP4015523A1 (en) * 2010-05-05 2022-06-22 New York University Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
RU2016110800A (ru) * 2013-09-25 2017-10-30 Пронутриа Биосайенсис, Инк. Составы и композиции для поддержания и увеличения мышечной массы, силы и результативности, и способы их производства и использования
EP3464349A4 (en) * 2016-05-23 2020-08-26 New York University COMPOSITIONS AND METHODS ASSOCIATED WITH ANTIBODIES TARGETING STAPHYLOCCAL LEUCOTOXINS
EP3638286A4 (en) * 2017-06-13 2021-03-10 Integrated Biotherapeutic Vaccines, Inc. IMMUNOGENIC COMPOSITIONS CONTAINING POLYPEPTIDES DERIVED FROM LEUCOCIDINS LUKA AND LUKB OF STAPHYLOCOCCUS AUREUS
CA3215751A1 (en) * 2021-04-02 2022-10-06 Janssen Pharmaceuticals, Inc. Staphylococcus aureus vaccine compositions

Similar Documents

Publication Publication Date Title
AU2016289492B2 (en) Vaccine against RSV
JP2023544834A5 (https=)
HRP20231496T1 (hr) Cistein proteaza
JP2018171063A5 (https=)
JP2025166834A5 (https=)
JP2002206000A5 (https=)
JP2021520818A5 (https=)
JP2013520426A5 (https=)
JP2014507146A5 (https=)
JP2015504052A5 (https=)
CN110892067A (zh) 热稳定性提高的phi29DNA聚合酶突变体
CN115443288A (zh) 一种免疫球蛋白降解酶IdeE的突变体
JP2022500409A5 (https=)
JP2005502332A5 (https=)
AR123187A1 (es) Vacuna de múltiples epítopos para el tratamiento de la enfermedad de alzheimer
JP2023544300A5 (https=)
JP2005511038A5 (https=)
JP2008522954A5 (https=)
WO2003090667A3 (fr) Composition immunogene ou vaccinale non immunosuppressive, comprenant une proteine e7 mutee du virus hpv-16
RU2007119376A (ru) Тимус - специфический белок
TW200716166A (en) Lawsonia intracellularis immunological proteins
CA2521038A1 (en) Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production
JP2025514872A5 (https=)
JP2023510544A5 (https=)
JP2024511641A5 (https=)